SCHEMBL2946361

SCHEMBL2946361

COCCOC1CCC2(CC1)NC(=O)C(c1c(C)cc(C)c(C)c1C)C2=O

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
BACE1 P56817 1/20 0.34
CD38 P28907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4498709 0.76
SCHEMBL13167977 0.75 ACACB (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL3268479 0.73 SPR (0.31)
SCHEMBL13167978 0.73 ACACB (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL1344157 0.73 ACACB (0.39) BACE1
SCHEMBL728681 0.72 ACACB (0.41)
SCHEMBL2886584 0.72 ACACB (0.33) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL3267352 0.72 ACACB (0.33)
SCHEMBL2951808 0.72 PKM (0.31)
SCHEMBL3273870 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314254-B2 Substituted spirocyclic ketoenols BAYER CROPSCIENCE AG (DE) 2012-11-20 US disclosed
US-20100234229-A1 Substituted Spirocyclic Ketoenols BAYER INTELLECTUAL PROPERTY GMBH (DE) 2010-09-16 US disclosed
US-7754654-B2 Substituted spirocyclic ketoenols BAYER CROPSCIENCE AG (DE) 2010-07-13 US disclosed
US-20070275858-A1 SUBSTITUTED SPIROCYCLIC KETOENOLS BAYER CROPSCIENCE AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275858-A1 SUBSTITUTED SPIROCYCLIC KETOENOLS PDHX, CYP19A1, AKR1A1 CHRM2 648/4885CHRM4 981/4885CHRM5 1009/4885
US-20100234229-A1 Substituted Spirocyclic Ketoenols HSD17B7, CYP17A1, HSD17B11 CHRM2 3196/4885CHRM4 3372/4885CHRM5 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.